Wai Chin Foo, M.D.
Department of Anatomical Pathology, Division of Pathology-Lab Medicine Div
About Dr. Wai Chin Foo
My primary role is to provide pathology support for collaborative translational and clinical studies involving gastrointestinal, pancreaticobiliary, and hepatic malignancies. I have a broad background in anatomic pathology with specific training in general oncologic pathology as well as additional sub-specialty training and expertise in gastrointestinal, pancreaticobiliary, and hepatic pathology. As a result of my extensive training, I am experienced in interpreting histology and immunohistochemistry, including in situ hybridization assays routinely used in my clinical practice. The current application is in my area of expertise and interest and builds on my prior work in pancreaticobiliary cancers.
Read More
Present Title & Affiliation
Primary Appointment
Professor, Department of Anatomic Pathology, Division of Pathology-Lab Medicine Div, The University of Texas MD Anderson Cancer Center, Houston, Texas
Dual/Joint/Adjunct Appointment
Professor, Department of Anatomic Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Education & Training
Degree-Granting Education
| 2006 | University of Alabama School of Medicine, Birmingham, Alabama, US, MD |
| 2002 | Birmingham Southern College, Birmingham, Alabama, US, Bachelor of Science |
Postgraduate Training
| 2020-2021 | Leadership Training, LEADing Others, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2018-2018 | EPIC Beaker Training, Pathologist Builder, Epic University, Verona, Wisconsin |
| 2011-2012 | Clinical Fellowship, Gastrointestinal and Liver Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2010-2011 | Clinical Fellowship, Surgical Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2009-2010 | Clinical Fellowship, Surgical Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts |
| 2006-2009 | Clinical Residency, Anatomic Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts |
Licenses & Certifications
| 2011 | American Board of Pathology - Diplomate, Anatomic Pathology |
| 2010 | Texas Medical Board - Full Medical License |
| 2010 | Commonwealth of Massachusetts - Full Medical License |
Experience & Service
Faculty Academic Appointments
Associate Professor, Department of Anatomic Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2018 - 2024
Assistant Professor, Department of Anatomic Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2012 - 2018
Administrative Appointments/Responsibilities
Deputy Department Chair, Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2023 - Present
Medical Director, Imaging Lab, Department of Anatomic Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - 2024
Committee Co-Chair, Anatomic Pathology Laboratory Information System (AP-LIS) Steering Committee, The University of Texas, M.D. Anderson Cancer Center, Houston, TX, 2018 - 2018
Committee Chair, Gastrointestinal & Liver Fellowship Program Evaluation Committee, Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2015 - 2021
Committee Chair, Gastrointestinal & Liver Fellowship Clinical Competency Committee, Department of Pathology, The University of Texas, M.D. Anderson Cancer Center, Houston, TX, 2015 - 2021
Chief Resident, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 2008 - 2009
Other Professional Positions
Expert Advisory Board Member, H. pylori IDN Research Project (HIRP) Working Group, Otsuka Pharmaceuticals, Houston, TX, 2017
Clinical Consultant, Gastrointestinal Pathology, Cancer Network, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, 2016 - Present
Member, The Cancer Genome Atlas (TCGA) Cholangiocarcinoma Analysis Working Group External Pathology Committee, Bethesda, MD, 2015 - 2017
Resident Member, The CAP Foundation, Grants sub-committee, Boston, MA, 2008 - 2009
International Pathology Coordinator, Partners in Health, Boston, MA, 2006 - 2010
Intramural Institutional Committee Activities
Member, Division of Pathology & Laboratory Medicine Travel Policy Committee, The University of Texas MD Anderson Cancer Center, 2025 - Present
Extramural Institutional Committee Activities
Member (Alternate), Beaker Executive Committee, The University of Texas MD Anderson Cancer Center, 2022 - Present
Member, Samuel J. Hassenbusch PRS Leadership & Institutional Service Award (LISA) Committee, The University of Texas MD Anderson Cancer Center, 2021 - 2021
Member, AP Beaker Steering Committee, The University of Texas MD Anderson Cancer Center, 2020 - Present
Member, Clinical Genomics Council, The University of Texas MD Anderson Cancer Center, 2020 - Present
Member, Division of Pathology & Laboratory Medicine (DP&LM) Digital Pathology Workforce Group, The University of Texas MD Anderson Cancer Center, 2020 - Present
Member, Physician Referral Service (PRS) Clinical Revenue Cycle Committee, The University of Texas MD Anderson Cancer Center, 2019 - 2021
Member, AP Beaker (Adoption) Steering Committee, The University of Texas MD Anderson Cancer Center, 2018 - 2020
Member, EHR Provider Experience Committee, The University of Texas MD Anderson Cancer Center, 2018 - 2019
Officer, Electronic Health Record (EHR) Officer Committee, The University of Texas MD Anderson Cancer Center, 2018 - 2024
Member, Administrative Support Action Plan Committee, The University of Texas MD Anderson Cancer Center, 2018 - 2019
Senator, Faculty Senate, The University of Texas MD Anderson Cancer Center, 2016 - 2021
Pathologist, Pathology Rare Tumors Working Group, The University of Texas MD Anderson Cancer Center, 2016 - Present
Member, Fellow Lecture Award Committee, The University of Texas MD Anderson Cancer Center, 2015 - 2019
Member, Gastrointestinal & Liver Pathology Fellowship Clinical Competency Committee, The University of Texas MD Anderson Cancer Center, 2015 - Present
Member, Gastrointestinal & Liver Pathology Fellowship Program Evaluation Committee, The University of Texas MD Anderson Cancer Center, 2015 - Present
Member, General Surgical Pathology Fellowship Program Evaluation Committee, The University of Texas MD Anderson Cancer Center, 2015 - 2020
Member, General Surgical Pathology Fellowship Clinical Competency Committee, The University of Texas MD Anderson Cancer Center, 2015 - 2020
Member, Oncology Steering Committee (OneConnect Adoption), The University of Texas MD Anderson Cancer Center, 2015 - 2016
Member, Frozen Section/Intraoperative Lab Committee, The University of Texas MD Anderson Cancer Center, 2014 - Present
Honors & Awards
| 2022 - 2024 | Multi-Year Appointment Award, The University of Texas, M.D. Anderson Cancer Center |
| 2003 | Arnold G. Diethelm Fellow, University of Alabama School of Medicine |
| 2002 - 2006 | Paul W. Burleson Scholar, University of Alabama School of Medicine |
| 2002 | Magna Cum Laude, Birmingham Southern College |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2025. Appendiceal Mucinous Neoplasms & Pseudomyxoma Peritonei: Updates. Surgical Pathology Lecture Series (MOSP1703). Houston, Texas, US.
- 2024. Primary Liver Tumors. Invited. Surgical Pathology Citywide Conference. Houston, Texas, US.
- 2022. Appendiceal Mucinous Neoplasms & Pseudomyxoma Peritonei: Updates. Surgical Pathology Lecture Series (MOSP1703). Houston, TX, US.
- 2022. Update on Pancreatic Neuroendocrine Neoplasms. Surgical Pathology Lecture Series (MOSP1703). Houston, TX, US.
- 2020. PD-L1 in Gastrointestinal Carcinomas and Complications from Checkpoint Inhibition. Conference. PD-L1 in Gastrointestinal Carcinomas and Complications from Checkpoint Inhibition. Houston, TX, US.
- 2019. Immune Checkpoint Inhibitors in GI Carcinomas: Biomarkers and Complications. Conference. Immune Checkpoint Inhibitors in GI Carcinomas: Biomarkers and Complications. Houston, TX, US.
- 2019. Appendiceal Mucinous Neoplasms & Pseudomyxoma Peritonei: Consensus & Updates. Conference. Appendiceal Mucinous Neoplasms & Pseudomyxoma Peritonei: Consensus & Updates. Houston, TX, US.
- 2017. Appendiceal Mucinous Neoplasms & Pseudomyxoma Peritonei: Moving Towards Consensus. Conference. Appendiceal Mucinous Neoplasms & Pseudomyxoma Peritonei: Moving Towards Consensus. Houston, TX, US.
- 2015. Appendiceal Mucinous Neoplasms. Conference. Appendiceal Mucinous Neoplasms. Houston, TX, US.
- 2014. Appendiceal Mucinous Neoplasms & Pseudomyxoma Peritonei. Conference. Appendiceal Mucinous Neoplasms & Pseudomyxoma Peritonei. Houston, TX, US.
National Presentations
- 2023. Considerations in Grading. Invited. Inaugural Appendix Cancer Think Tank. Nashville, Tennessee, US.
- 2022. CD8 Singleplex Image Analysis. Invited. CD8 Singleplex Image Analysis, US.
- 2019. BRAF V600E and PD-L1 Biomarker Analysis in Cutaneous Oncology and Therapy-related Skin and GI toxicities: Review, Update, and Pitfalls!. Conference. BRAF V600E and PD-L1 Biomarker Analysis in Cutaneous Oncology and Therapy-related Skin and GI toxicities: Review, Update, and Pitfalls!. Phoenix, AZ, US.
- 2017. High level microsatellite instability in appendiceal carcinomas. Conference. High level microsatellite instability in appendiceal carcinomas. San Antonio, TX, US.
- 2016. Completion resections of low grade appendiceal mucinous neoplasm with extra-appendiceal mucin and appendiceal margin involvement. Conference. Completion resections of low grade appendiceal mucinous neoplasm with extra-appendiceal mucin and appendiceal margin involvement. Seattle, WA, US.
- 2011. FAP-assodated desmoid fibromatosis: a comparison to their sporadic counterparts. Conference. FAP-assodated desmoid fibromatosis: a comparison to their sporadic counterparts. San Antonio, TX, US.
- 2010. Immunohistochemical staining for TLE1 distinguishes synovial sarcoma from histologic mimics. Conference. Immunohistochemical staining for TLE1 distinguishes synovial sarcoma from histologic mimics. Washington, DC, US.
- 2009. Partners in pathology: a model for department-wide educational experience. Conference. Partners in pathology: a model for department-wide educational experience. Boston, MA, US.
- 2008. The accuracy of pretreatment biopsy of pleural malignant mesothelioma in predicting histopathologic type in extrapleural pneumonectomy. Conference. The accuracy of pretreatment biopsy of pleural malignant mesothelioma in predicting histopathologic type in extrapleural pneumonectomy. Denver, CO, US.
International Presentations
- 2025. Pancreatic Neuroendocrine Tumors: Evolving Concepts. Invited. Indonesia Pathology ECHO (IPE). Houston, US.
- 2023. Update in Pancreatic Neuroendocrine Neoplasms. Conference. Update in Pancreatic Neuroendocrine Neoplasms. Penang, MY.
- 2023. Pancreatic Cysts: the Good, the Bad, & the Challenging. Conference. Pancreatic Cysts: the Good, the Bad, & the Challenging. Penang, MY.
- 2019. Interesting Pancreatic Cases. Conference. Interesting Pancreatic Cases. Malacca, MY.
- 2019. Updates in Pancreatic Mucinous Neoplasms. Conference. Updates in Pancreatic Mucinous Neoplasms. Malacca, MY.
- 2019. Updates in Pancreatic Neuroendocrine Neoplasms. Conference. Updates in Pancreatic Neuroendocrine Neoplasms. Malacca, MY.
- 2019. GI Complications in the Age of Immunotherapy. Conference. GI Complications in the Age of Immunotherapy. Mexico City, MX.
- 2019. Gastric Cancer: Updates & Biomarkers. Conference. Gastric Cancer: Updates & Biomarkers. Mexico City, MX.
- 2018. Appendiceal Mucinous Neoplasms & Pseudomyxoma Peritonei: Consensus & Updates. Conference. Appendiceal Mucinous Neoplasms & Pseudomyxoma Peritonei: Consensus & Updates. San Salvador, SV.
- 2017. Appendiceal Mucinous Neoplasms & Pseudomyxoma Peritonei: Moving Towards Consensus. Conference. Appendiceal Mucinous Neoplasms & Pseudomyxoma Peritonei: Moving Towards Consensus. Bangkok, TH.
- 2017. GI Complications in the Age of Immunotherapy. Conference. GI Complications in the Age of Immunotherapy. Bangkok, TH.
- 2012. Loss of PTEN expression in pancreatic ductal adenocarcinoma is associated with poor survival. Conference. Loss of PTEN expression in pancreatic ductal adenocarcinoma is associated with poor survival. Vancouver, CA.
- 2012. Muscularis mucosae duplication and musculo-fibrous anomalies in squamous dysplasia of the esophagus. Conference. Muscularis mucosae duplication and musculo-fibrous anomalies in squamous dysplasia of the esophagus. Cape Town, ZA.
Grant & Contract Support
| Date: | 2022 - 2023 |
| Title: | S20-089F2 ComboMATCH |
| Funding Source: | NIH/NCI |
| Role: | Co-PI |
| ID: | FP00018431 |
| Date: | 2022 - 2023 |
| Title: | S20-089F1 MDNet - Site Management |
| Funding Source: | NIH/NCI |
| Role: | Collaborator |
| ID: | 60653 |
| Date: | 2019 - 2026 |
| Title: | Randomized Study Evaluating Molecular Profiling and Targeted Agents in Metastatic Cancer: Initiative for Molecular Profiling and Advanced Cancer Therapy (IMPACT II) |
| Funding Source: | Tempus Labs, Inc |
| Role: | Co-PI |
| ID: | PA12-1161 |
| Date: | 2018 - 2025 |
| Title: | An Exploratory Study of Nivolumab with or without Ipilimumab According to Tumor CD8 Expression in Patients with Advanced Cancer |
| Funding Source: | Parker Institute for Cancer |
| Role: | Principal Investigator-MDACC |
| ID: | 2017-0446 |
| Date: | 1998 - 2018 |
| Title: | Cancer Center Support (CORE) Grant |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | 3P0CA016672-41S9 |
Selected Publications
Peer-Reviewed Articles
- Lapelusa, M, Qiao, W, Iorgulescu, B, San Lucas, FA, Patel, KP, Bhamidipati, D, Thomas, J, You, YN, Foo, WC, Maru, D, Thirumurthi, S, Morris, VK, Kopetz, S, Overman, MJ, Ludford, K. Long-Term Efficacy of Pembrolizumab and the Clinical Utility of ctDNA in Locally Advanced dMMR/MSI-H Solid Tumors. Nature communications 16(1), 2025. e-Pub 2025. PMID: 40374594.
- Seldomridge AN, White MG, Scally C, Royal RE, Routbort M, Iorgulescu J, Overman MJ, Lee SM, Foo WC, Taggart MW, Song Y, Mansfield PF, Fournier KF, Shen JP, Helmink BA. Clinicopathologic and Molecular Characteristics of High-Grade Appendiceal Mucinous Neoplasms. Ann Surg Oncol, 2025. e-Pub 2025. PMID: 41225239.
- Morris VK, Parseghian CM, Bahrambeigi V, Abdelfattah N, Xiao L, Agrawal A, Lin K, Raghav KPS, Wolff RA, Dasari A, Huey RW, Kee BK, Overman MJ, Willis JA, Le PH, Escano M, Baig YC, Pan K, Menter D, Tam AL, Foo WC, Shen L, Lee HM, Gallup TD, Margain C, Gallup D, Rajapakshe KI, Guerrero PA, Wang J, Corcoran RB, Maitra A, Yun K, Kopetz S. Phase 1/2 trial of encorafenib, cetuximab, and nivolumab in microsatellite stable BRAF(V600E) metastatic colorectal cancer. Cancer Cell 43(11):2106-2118.e3, 2025. e-Pub 2025. PMID: 40882637.
- Kataoka K, Mauer M, Shiozawa M, Marreaud S, Kishi Y, Cabrieto J, Onaya H, Ducreux M, Suto T, Kang HC, Matsuhashi N, Fung A, Yasui M, Rivoire M, Tonooka T, Troisi RI, Nakamura K, Stattner S, Kinugasa Y, Foo WC, Desolneux G, Bonhomme B, Ikeda M, Caballero C, Lordick F, Kanemitsu Y, Evrard S. Diagnostic Accuracy of Imaging in Assessing Nonviability of Disappearing Colorectal Liver Metastasis. JAMA Surg 160(11):1212-1220, 2025. e-Pub 2025. PMID: 40960802.
- Saleem, A, Shaikh, AS, Overman, MJ, Naik, SA, Foo, WC, Vilar Sanchez, E, Triadafilopoulos, G, Raju, GS, Richards, DM. Vanished! Auto-amputated Ileal Polyp in a Patient with Lynch Syndrome. Digestive diseases and sciences 70(7):2292-2296, 2025. e-Pub 2025. PMID: 40266505.
- Peddireddy, A, Huey, RW, Wolff, RA, Lin, K, Mitchell, J, Scofield, LC, Jacob, S, Nguyen, DV, Rogers, JE, Portier, S, Foo, WC, Eng, C, Morris, VK. Clinicopathologic Features Associated with Survival for Immune Checkpoint Blockade in Patients with Metastatic Anal Cancer. Cancers 17(6), 2025. e-Pub 2025. PMID: 40149273.
- Tsimberidou AM, Alayli FA, Okrah K, Drakaki A, Khalil DN, Kummar S, Khan SA, Hodi FS, Oh DY, Cabanski CR, Gautam S, Meier SL, Amouzgar M, Pfeiffer SM, Kageyama R, Yang E, Spasic M, Tetzlaff MT, Foo WC, Hollmann TJ, Li Y, Adamow M, Wong P, Moore JS, Velichko S, Chen RO, Kumar D, Bucktrout S, Ibrahim R, Dugan U, Salvador L, Hubbard-Lucey VM, O'Donnell-Tormey J, Santulli-Marotto S, Butterfield LH, Da Silva DM, Fairchild J, LaVallee TM, Padron LJ, Sharma P. Immunologic signatures of response and resistance to nivolumab with ipilimumab in advanced metastatic cancer. J Exp Med 221(10), 2024. e-Pub 2024. PMID: 39190534.
- Sun H, Kang EY, Chen H, Sweeney KJ, Suchko M, Wu Y, Wen J, Krishnamurthy S, Albarracin CT, Ding QQ, Foo WC, Sahin AA. Immunohistochemical assessment of HER2 low breast cancer: interobserver reproducibility and correlation with digital image analysis. Breast Cancer Res Treat 205(2):403-411, 2024. e-Pub 2024. PMID: 38441847.
- Yousef, A, Yousef, M, Zeineddine, MA, More, A, Fanaeian, M, Chowdhury, S, Knafl, M, Edelkamp, P, Ito, I, Gu, Y, Pattalachinti, V, Naini, ZA, Zeineddine, F, Peterson, J, Alfaro, KD, Foo, WC, Jin, J, Bhutiani, N, Higbie, V, Scally, CP, Kee, BK, Kopetz, S, Goldstein, D, Strach, M, Williamson, A, Aziz, O, Barriuso, J, Uppal, A, White, MG, Helmink, BA, Fournier, KF, Raghav, KS, Taggart, MW, Overman, MJ, Shen, JY. Serum Tumor Markers and Outcomes in Patients With Appendiceal Adenocarcinoma. JAMA Network Open 7(2):e240260, 2024. e-Pub 2024. PMID: 38416491.
- White, MG, Bhutiani, N, Helmink, BA, Taggart, MW, Foo, WC, Mansfield, PF, Fournier, KF, Scally, CP. ASO Visual Abstract. Annals of surgical oncology 30(13):8176, 2023. e-Pub 2023. PMID: 37728822.
- Dhingra, S, Taggart, MW, Foo, WC, Rashid, A, Heredia, MM, May, SB, Buren, GV, Fisher, WE, Wang, H. Interobserver Variability and Challenges in Intraoperative Frozen Section Evaluation of Pancreatic Margins in Pancreatectomy Specimens. Annals of clinical and laboratory science 53(6):847-860, 2023. e-Pub 2023. PMID: 38182140.
- Shen JP, Yousef AM, Zeineddine FA, Zeineddine MA, Tidwell RS, Beaty KA, Scofield LC, Rafeeq S, Hornstein N, Lano E, Eng C, Matamoros A, Foo WC, Uppal A, Scally C, Mansfield P, Taggart M, Raghav KP, Overman MJ, Fournier K. Efficacy of Systemic Chemotherapy in Patients with Low-grade Mucinous Appendiceal Adenocarcinoma: A Randomized Crossover Trial. JAMA Netw Open 6(6):e2316161, 2023. e-Pub 2023. PMID: 37261831.
- Ludford K, Ho WJ, Thomas JV, Raghav KPS, Murphy MB, Fleming ND, Lee MS, Smaglo BG, You YN, Tillman MM, Kamiya-Matsuoka C, Thirumurthi S, Messick C, Johnson B, Vilar E, Dasari A, Shin S, Hernandez A, Yuan X, Yang H, Foo WC, Qiao W, Maru D, Kopetz S, Overman MJ. Neoadjuvant Pembrolizumab in Localized Microsatellite Instability High/Deficient Mismatch Repair Solid Tumors. J Clin Oncol 41(12):JCO2201351, 2023. e-Pub 2023. PMID: 36623241.
- Hernandez S, Das P, Holliday EB, Shen L, Lu W, Johnson B, Messick CA, Taniguchi CM, Skibber J, Ludmir EB, You YN, Li Smith G, Bednarski B, Kostousov L, Koay EJ, Minsky BD, Tillman M, Portier S, Eng C, Koong AC, Chang GJ, Foo WC, Wang J, Solis Soto L, Morris VK. Differential Spatial Gene and Protein Expression Associated with Recurrence Following Chemoradiation for Localized Anal Squamous Cell Cancer. Cancers 15(6):1701, 2023. e-Pub 2023. PMID: 36980587.
- Zhou Y, Medik YB, Patel B, Zamler DB, Chen S, Chapman T, Schneider S, Park EM, Babcock RL, Chrisikos TT, Kahn LM, Dyevoich AM, Pineda JE, Wong MC, Mishra AK, Cass SH, Cogdill AP, Johnson DH, Johnson SB, Wani K, Ledesma DA, Hudgens CW, Wang J, Wadud Khan MA, Peterson CB, Joon AY, Peng W, Li HS, Arora R, Tang X, Raso MG, Zhang X, Foo WC, Tetzlaff MT, Diehl GE, Clise-Dwyer K, Whitley EM, Gubin MM, Allison JP, Hwu P, Ajami NJ, Diab A, Wargo JA, Watowich SS. Intestinal toxicity to CTLA-4 blockade driven by IL-6 and myeloid infiltration. J Exp Med 220(2), 2023. e-Pub 2023. PMID: 36367776.
- Erstad DJ, Robinson KA, Beaty K, Rafeeq S, Chiang YJ, Raghav K, Shen JP, Overman MJ, Foo WC, Taggart MW, Mansfield PF, Royal RE, Fournier KF, Scally CP. Prognostic significance of acellular mucin in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) for appendiceal neoplasms. Langenbecks Arch Surg 408(1):110, 2023. e-Pub 2023. PMID: 36853519.
- Hailemichael Y, Johnson DH, Abdel-Wahab N, Foo WC, Bentebibel SE, Daher M, Haymaker C, Wani K, Saberian C, Ogata D, Kim ST, Nurieva R, Lazar AJ, Abu-Sbeih H, Fa'ak F, Mathew A, Wang Y, Falohun A, Trinh V, Zobniw C, Spillson C, Burks JK, Awiwi M, Elsayes K, Soto LS, Melendez BD, Davies MA, Wargo J, Curry J, Yee C, Lizee G, Singh S, Sharma P, Allison JP, Hwu P, Ekmekcioglu S, Diab A. Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity. Cancer Cell 40(5):509-523.e6, 2022. e-Pub 2022. PMID: 35537412.
- Carapeto F, Bozorgui B, Shroff RT, Chagani S, Solis Soto L, Foo WC, Wistuba I, Meric-Bernstam F, Shalaby A, Javle M, Korkut A, Kwong LN. The Immunogenomic Landscape of Resected Intrahepatic Cholangiocarcinoma. Hepatology 75(2):297-308, 2022. e-Pub 2022. PMID: 34510503.
- Corsini EM, Foo WC, Mitchell KG, Zhou N, Maru DM, Ajani JA, Hofstetter WL, Working Group EA, Correa AM, Antonoff MB, Lin SH, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL. Esophageal adenocarcinoma with any component of signet ring cells portends poor prognosis and response to neoadjuvant therapy. J Thorac Cardiovasc Surg 162(5):1404-1412.e2, 2021. e-Pub 2020. PMID: 33010880.
- Marcus R, Ferri-Borgogno S, Hosein A, Foo WC, Ghosh B, Zhao J, Rajapakshe K, Brugarolas J, Maitra A, Gupta S. Oncogenic KRAS Requires Complete Loss of BAP1 Function for Development of Murine Intrahepatic Cholangiocarcinoma. Cancers (Basel) 13(22), 2021. e-Pub 2021. PMID: 34830866.
- Khurana S, Abu-Sbeih H, Ma W, Qiao W, Foo WC, Richards DM, Thomas AS, Khan A, Zhang HC, Wang Y. Clinical Characteristics and Outcomes of Eosinophilic Colitis in Patients With Cancer. Am J Clin Oncol 44(8):395-401, 2021. e-Pub 2021. PMID: 34091476.
- Kanikarla Marie P, Haymaker C, Parra ER, Kim YU, Lazcano R, Gite S, Lorenzini D, Wistuba II, Tidwell RSS, Song X, Foo WC, Maru DM, Chun YS, Futreal A, Kee B, Menter D, Solis L, Tzeng CW, Parseghian C, Raghav K, Morris V, Chang CC, Jenq R, Tam A, Bernatchez C, Kopetz S, Vauthey JN, Overman MJ. Pilot Clinical Trial of Perioperative Durvalumab and Tremelimumab in the Treatment of Resectable Colorectal Cancer Liver Metastases. Clin Cancer Res 27(11):3039-3049, 2021. e-Pub 2021. PMID: 33811152.
- Hester, R, Advani, S, Rashid, A, Holliday, EB, Messick, C, Das, P, You, YN, Taniguchi, C, Koay, EJ, Bednarski, BK, Rodriguez-Bigas, MA, Skibber, JM, Wolff, RA, Chang, GJ, Minsky, B, Foo, WC, Rothschild, ND, Morris, VK, Eng, C. CEA as a blood-based biomarker in anal cancer. Oncotarget 12(11):1037-1045, 2021. e-Pub 2021. PMID: 34084278.
- Hester R, Advani S, Rashid A, Holliday E, Messick C, Das P, You Y, Taniguchi C, Koay EJ, Bednarski B, Rodriguez-Bigas M, Skibber J, Wolff R, Chang GJ, Minsky BD, Foo WC, Rothschild N, Morris VK, Eng C. CEA as a blood-based biomarker in anal cancer. Oncotarget 12(11):1037-1045. e-Pub 2021.
- Ludford K, Cohen R, Svrcek M, Foo WC, Colle R, Parc Y, Thomas JV, Morris VK, Kopetz S, Chang GJ, Overman M, Andre T. Pathological tumor response following immune checkpoint blockade for deficient mismatch repair advanced colorectal cancer. J Natl Cancer Inst 113(2):208-211, 2021. e-Pub 2021. PMID: 32294214.
- Coronel M, Lanke G, Campbell D, Coronel E, Tzeng CD, Foo WC, Lee JH. Performing endoscopic retrograde cholangiopancreatography and endoscopic ultrasound for management of malignant bile duct obstruction in a patient with a situs inversus totalis. ACG Case Rep J 7(12), 2020. e-Pub 2020. PMID: 33324708.
- Raghav K, Shen JP, Jacome AA, Guerra JL, Scally CP, Taggart MW, Foo WC, Matamoros A, Shaw KR, Fournier K, Overman MJ, Eng C. Integrated clinico-molecular profiling of appendiceal adenocarcinoma reveals a unique grade-driven entity distinct from colorectal cancer. Br J Cancer 123(1262-1270), 2020. e-Pub 2020. PMID: 32733093.
- Toomey S, Gunther J, Carr A, Weksberg DC, Thomas V, Salvucci M, Bacon O, Sherif EM, Fay J, Kay EW, Sheehan KM, McNamara DA, Sanders KL, Mathew G, Breathnach OS, Grogan L, Morris PG, Foo WC, You YN, Prehn JH, O'Neill B, Krishnan S, Hennessy BT, Furney SJ. Genomic and Transcriptomic Characterisation of Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer. Cancers (Basel) 12(7). e-Pub 2020. PMID: 32640573.
- Ge PS, Angsuwatcharakon P, Chang GJ, Foo WC, Tillman MM, Aihara H. The suture pulley countertraction method for challenging rectal endoscopic submucosal dissection. VideoGIE 5(5):210-212, 2020. e-Pub 2020. PMID: 32426573.
- Tang T, Abu-Sbeih H, Ma W, Lu Y, Luo W, Foo WC, Richards DM, Halperin DM, Ge PS, Wang Y. Gastrointestinal Injury Related to Antiangiogenesis Cancer Therapy. Clin Colorectal Cancer 19(3):117-123. e-Pub 2020. PMID: 32284253.
- Abu-Sbeih H, Ali FS, Chen E, Mallepally N, Luo W, Lu Y, Foo WC, Qiao W, Okhuysen PC, Adachi JA, Hachem RY, Altan M, Jenq RR, Wang Y. Neutropenic Enterocolitis: Clinical Features and Outcomes. Dis Colon Rectum 63(3):381-388, 2020. e-Pub 2020. PMID: 31842164.
- Lopez A, Harada K, Chen HC, Bhutani MS, Weston B, Lee JH, Maru DM, Foo WC, Rogers JE, Thomas I, Amlashi FG, Blum-Murphy MA, Rice DC, Zhao M, Hofstetter WL, Nguyen Q, Ajani JA. Taxane-based or platinum-based combination chemotherapy given concurrently with radiation followed by surgery resulting in high cure rates in esophageal cancer patients. Medicine (Baltimore) 99(9):e19295, 2020. e-Pub 2020. PMID: 32118743.
- Chirieac LR, Hung YP, Foo WC, Hofer MD, VanderLaan PA, Richards WG, Sugarbaker DJ, Bueno R. Diagnostic value of biopsy sampling in predicting histology in patients with diffuse malignant pleural mesothelioma. Cancer, 2019. e-Pub 2019. PMID: 31390057.
- Abu-Sbeih H, Tang T, Ali FS, Luo W, Neelapu SS, Westin JR, Okhuysen PC, Foo WC, Curry JL, Richards DM, Ge PS, Wang Y. Gastrointestinal adverse events observed after chimeric antigen receptor T-cell therapy. Am J Clin Oncol 42(10):789-796, 2019. e-Pub 2019. PMID: 31478934.
- Hui L, Rashid A, Foo WC, Katz MH, Chatterjee D, Wang H, Fleming JB, Tamm EP, Wang H. Significance of T1a and T1b carcinoma arising in mucinous cystic neoplasm of pancreas. Am J Surg Pathol, 2018. e-Pub 2018. PMID: 29462092.
- Sagebiel TL, Mohamed A, Matamoros A, Taggart MW, Doamekpor F, Raghav KP, Mann GN, Mansfield PF, Eng C, Royal RE, Foo WC, Ensor JE, Fournier KF, Overman MJ. Utility of Appendiceal Calcifications Detected on Computed Tomography as a Predictor for an Underlying Appendiceal Epithelial Neoplasm. Ann Surg Oncol 24(12):3667-3672, 2017. e-Pub 2017. PMID: 28831698.
- Morris V, Rao X, Pickering C, Foo WC, Rashid A, Eterovic A, Kim TB, Chen K, Wang J, Shaw K, and Eng C. Comprehensive Genomic Profiing of Metastatic Squamous Cell Carcinoma of the Anal Canal. Mol Cancer Res 15(11), 2017. e-Pub 2017. PMID: 28784613.
- Chatterjee D, Katz MH, Foo WC, Sundar M, Wang H, Varadhachary GR, Wolff RA, Lee JE, Maitra A, Fleming JB, Rashid A, Wang H. Prognostic Significance of New AJCC Tumor Stage in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Therapy. Am J Surg Pathol 41(8):1097-1104, 2017. e-Pub 2017. PMID: 28614206.
- Morris VK, Salem ME, Nimeiri H, Iqbal S, Singh P, Ciombor K, Polite B, Deming D, Chan E, Wade JL, Xiao L, Bekaii-Saab T, Vence L, Blando J, Mahvash A, Foo WC, Ohaji C, Pasia M, Bland G, Ohinata A, Rogers J, Mehdizadeh A, Banks K, Lanman R, Wolff RA, Streicher H, Allison J, Sharma P, Eng C. Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study. Lancet Oncol 18(4):446-453, 2017. e-Pub 2017. PMID: 28223062.
- Farshidfar F, Zheng S, Gingras MC, Newton Y, Shih J, Robertson AG, Hinoue T, Hoadley KA, Gibb EA, Roszik J, Covington KR, Wu CC, Shinbrot E, Stransky N, Hegde A, Yang JD, Reznik E, Sadeghi S, Pedamallu CS, Ojesina AI, Hess JM, Auman JT, Rhie SK, Bowlby R, Borad MJ, Atlas Network CG, Zhu AX, Stuart JM, Sander C, Akbani R, Cherniack AD, Deshpande V, Mounajjed T, Foo WC, Torbenson MS, Kleiner DE, Laird PW, Wheeler DA, McRee AJ, Bathe OF, Andersen JB, Bardeesy N, Roberts LR, Kwong LN. Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles. Cell Rep 18(11):2780-2794, 2017. e-Pub 2017. PMID: 28297679.
- Khan M, Korphaisarn K, Saif A, Foo WC, Kopetz S. Early-Onset Signet-Ring Cell Adenocarcinoma of the Colon: A Case Report and Review of the Literature. Case Rep Oncol Med 2017, 2017. e-Pub 2017. PMID: 28326211.
- Gutierrez C, Kebriaei P, Turner KA, Yemelyanova A, Ariza-Heredia EJ, Foo WC. A unique presentation of acute liver failure from herpes simplex virus hepatitis. Transpl Infect Dis 18(4):592-4, 2016. e-Pub 2016. PMID: 27222930.
- Rojas A, Zhang P, Wang Y, Foo WC, Muñoz NM, Xiao L, Wang J, Gores GJ, Hung MC, Blechacz B. A Positive TGF-β/c-KIT Feedback Loop Drives Tumor Progression in Advanced Primary Liver Cancer. Neoplasia 18(6):371-86, 2016. e-Pub 2016. PMID: 27292026.
- Sathyanarayanan V, Foo WC, Fanale M, Westin J. Deeper Insights Into Vanishing Bile Duct Syndrome in Lymphoma: A Perplexing Entity. Clin Lymphoma Myeloma Leuk 16(5):e65-70, 2016. e-Pub 2016. PMID: 27050323.
- Overman MJ, Eng C, Raghav K, Matamoros A, Taggart M, Foo WC, Fournier K. Challenges of efficacy assessments in pseudomyxoma peritonea. Oncologist 20(3):e3-4, 2015. e-Pub 2015. PMID: 25745054.
- Foo WC, Wang H, Prieto VG, Fleming JB, Abraham SC. Squamoid cystosis of pancreatic ducts: a variant of a newly-described cystic lesion, with evidence for an obstructive etiology. Rare Tumors 6(3):5286, 2014. e-Pub 2014. PMID: 25276318.
- Liu C, Karam R, Zhou Y, Su F, Ji Y, Li G, Xu G, Lu L, Wang C, Song M, Zhu J, Wang Y, Zhao Y, Foo WC, Zuo M, Valasek MA, Javle M, Wilkinson MF, Lu Y. The UPF1 RNA surveillance gene is commonly mutated in pancreatic adenosquamous carcinoma. Nat Med 20(6):596-8, 2014. e-Pub 2014. PMID: 24859531.
- Foo WC, Rashid A, Wang H, Katz MH, Lee JE, Pisters PW, Wolff RA, Abbruzzese JL, Fleming JB, Wang H. Loss of phosphatase and tensin homolog expression is associated with recurrence and poor prognosis in patients with pancreatic ductal adenocarcinoma. Hum Pathol 44(6):1024-30, 2013. e-Pub 2013. PMID: 23260327.
- Colombo C, Foo WC, Whiting D, Young ED, Lusby K, Pollock RE, Lazar AJ, Lev D. FAP-related desmoid tumors: a series of 44 patients evaluated in a cancer referral center. Histol Histopathol 27(5):641-9, 2012. e-Pub 2012. PMID: 22419028.
- Krishna SG, Stroehlein JR, Foo WC, Suzuki R, Reddy SR, Bhutani MS. Iatrogenic infection of a colonic cystic lymphangioma following cold-forceps biopsy. Endoscopy 44(Supplement S2):E104-5, 2012. e-Pub 2012. PMID: 22477167.
- Foo WC, Cruise M, Wick MR, Hornick JL. Immunohistochemical staining for TLE1 distinguishes synovial sarcoma from histologic mimics. Am J Clin Pathol 135(6):839-844, 2011. e-Pub 2011. PMID: 21571956.
- Carlson JW, Lyon E, Walton D, Foo WC Sievers AC, Shulman LN, Farmer P, Nose V, Jr MD. Partners in pathology: a collaborative model to bring pathology to resource poor settings. Am J Surg Pathol 34(1):118-123, 2010. e-Pub 2010. PMID: 19898229.
Invited Articles
- Cox VL, Saeed Bamashmos AA, Foo WC, Gupta S, Yedururi S, Garg N, Kang HC. Lynch syndrome: genomics update and imaging review. Radiographics 38(2):483-499, 2018. e-Pub 2018.
- Foo WC, Liegl-Atzwanger B, Lazar AJ. Pathology of gastrointestinal stromal tumors. Clin Med Insights Pathol 5, 2012. e-Pub 2012. PMID: 22855636.
Review Articles
- Holowatyj AN, Overman MJ, Votanopoulos KI, Lowy AM, Wagner P, Washington MK, Eng C, Foo WC, Goldberg RM, Hosseini M, Idrees K, Johnson DB, Shergill A, Ward E, Zachos NC, Shelton D. Defining a 'cells to society' research framework for appendiceal tumours. Nat Rev Cancer 25(4):293-315, 2025. e-Pub 2025. PMID: 39979656.
Abstracts
- Elzamly S, Al-Attar M, Taggart M, Foo WC, Maru D, Chatterjee D. SMARCA4-Deficient Carcinoma of the Esophagus: Diagnostic Challenges with Synaptophysin Expression and Therapeutic Implications. Gastrointestinal Pathology:S703, 2024. e-Pub 2024.
- Taherian M, Taggart M, Maru D, Foo WC, Rashid A, Abraham S, Chatterjee D. Clinicopathologic Features of Esophageal Adenocarcinomas with Enteroblastic Differentiation. Gastrointestinal Pathology:S638, 2023. e-Pub 2023.
- Lenskaya V, Jiang X, Foo WC, Abraham S, Taggart M, Walsh G, Swisher S, Ning J, Aung P, Curry J, Cho WC, Torres-Cabala C, Ivan D, Prieto V, Amaria R, Tawbi H, Nagarajan P. Primary Mucosal Melanoma of the Esophagus: Clinicopathologic and Molecular Analysis. Gastrointestinal Pathology:S590, 2023. e-Pub 2023.
- Chapman L, White MG, Willett A, Beaty K, Matamoros A, Taggart M, Foo WC, Scally C, Mansfield P, Malpica A, Raghav KP, Fournier KF. Neoadjuvant Chemotherapy (NACT) in Malignant Peritoneal Mesothelioma (MPeM) treated with Cytoreduction (CRS) and Heated Intraperitoneal Chemotherapy (HIPC). Eur J Surg Oncol 49(2):e60, 2023. e-Pub 2023.
- Peddireddy AS, Johnson B, Wolff RA, Huey R, Holliday E, Das P, Skibber JM, Portier S, Foo WC, Halperin D, Morris VK. Survival Benefit to Immunotherapy According to Site of Organ Involvement in Metastatic Anal Cancer. J Clin Oncol 41(Supplemental 4):3-3, 2023. e-Pub 2023.
- Alayi F, Okrah K, Tsimberidou A, Drakaki A, Khalil D, Khan S, Hodi S, Oh D, Amouzgar M, Guatam S, Kageyama R, Pfeiffer S, Meier S, Cabanski C, Da Silva D, Kumar D, Santulli-Marotto S, Tetzlaff M, Foo WC, Hollman T, Li Y, Adamow M, Wong P, Spasic M, Chen R, Bucktrout S, Fairchild J, Butterfield L, LaVallee T, Padron L, Salvador L, O'Donnell-Tormey J, Dugan U, Sharma P. AMADEUS Trial: Tumor Agnostic Pre- and Ontreatment Biomarkers of Response to Nivolumab Plus Ipilimumab Correlate with Ontreatment Tumoral T Cell Infiltration. J ImmunoTher Cancer 10:A614-A614, 2022. e-Pub 2022.
- Morris VK, Parseghian CM, Escano M, Johnson B, Raghav KP, Dasari A, Huey R, Overman MJ, Willis J, Lee MS, Wolff RA, Kee BK, Le P, Margain C, Gallup D, Tam A, Foo WC, Xiao L, Yun K, Kopetz S. Phase I/II Trial of Encorafenib, Cetuximab, and Nivolumab in Patients with Microsatellite Stable (MSS), BRAFV600E Metastatic Colorectal Cancer. J Clin Oncol 40(Supplemental 16):3598-3598, 2022. e-Pub 2022.
- Johnson DH, Hailemichael Y, Bentebibel SE, Abdel-Wahab N, Cho S, Foo WC, Wani K, Watowich SS, Ekmekcioglu S, Diab A. Th17 Inhibition with Interleukin 6 Blockade Decouples Immunotoxicity from Tumor Immunity. Cancer Res 82(Supplemental 12):4177-4177, 2022. e-Pub 2022.
- Taherian M, Waters R, Foo WC, Maru D, Abraham S, Rashid A, Wang H, Wei D, Taggart M, Chatterjee D. Blinded Histologic Review to Classify Grade 3 Pancreatic Epithelial Neuroendocrine Neoplasms Shows Only Slight Correlation Among Experienced Gastrointestinal Pathologists. Lab Invest 102(Supplemental 1):1234-1235, 2022. e-Pub 2022.
- Tong YT, Foo WC, Rashid A, Waters R, Abraham S, Chatterjee D, Taggart M. Defining Amphicrine Carcinoma of the Gastrointestinal Tract: A Single Institutional. Lab Invest 102(Supplemental 1):530-532, 2022. e-Pub 2022. PMID: 35302089.
- Morris VK, Parseghian CM, Escano M, Johnson B, Raghav KP, Dasari A, Huey R, Overman MJ, Willis J, Lee MS, Wolff RA, Kee BK, Shen JP, Morelli MP, Tam A, Foo WC, Xiao L, Kopetz S. Phase I/II Trial of Encorafenib, Cetuximab, and Nivolumab in Patients with Microsatellite Stable, BRAFV600E Metastatic Colorectal Cancer. J Clin Oncol 40(Supplemental 4):12-12, 2022. e-Pub 2022.
- Diab A, Abdel-Wahab N, Johnson DH, Hailemichael Y, Foo WC, Bentebibel SE, Lizee GA, Ekmecioglu S. Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity. Ann Oncol 32:S1403, 2021. e-Pub 2021.
- Ludford K, Raghav K, Blum-Murphy MA, Fleming ND, Nelson D, Lee MS, Smaglo BG, You YN, Tillman MM, Kamiya-Matsuoka C, Thirumurthi S, Messick C, Johnson B, Vilar E, Thomas J, Foo WC, Qiao W, Kopetz S, Overman MJ. Neoadjuvant pembrolizumab in localized/locally advanced solid tumors with mismatch repair deficiency. Ann Oncol 32:S1210, 2021. e-Pub 2021.
- Ludford K, Raghav K, Blum MA, Fleming ND, Nelson DA, Lee MS, Smaglo BG, You Y, Tillman MM, Kamiya-Matsuoka C, Thirumurthi S, Messick C, Johnson B, Vilar-Sanchez E, Dasari A, Thomas JV, Foo WC, Qiao W, Kopetz S, Overman MJ. Safety and efficacy of neoadjuvant pembrolizumab in mismatch repair deficient localized/locally advanced solid tumors. J Clin Oncol 39(Supplemental 15):2520-2520. e-Pub 2021.
- Marcus R, Hosein A, Ferri-Borgogno S, Foo WC, Rajapakshe K, Gupta S, Maitra A. The functional role of epigenetic regulators in intrahepatic cholangiocarcinoma. HPB 23:S483-S484, 2021. e-Pub 2021.
- Carapeto F, Soto LM, Foo WC, Lu W, Fawaz EAV, Villaseca MA, Pizarrov EA, Araya JC, Wistuba II, Milind J, Shubham P, Kwong L. Immunological and mutational landscape of gallbladder adenocarcinoma. Cancer Res 80(Supplemental 16):2658. e-Pub 2020.
- Khurana S, Abu-Sbeih H, Ma W, Foo WC, Zhang HC, Wang Y. Eosinophilic colitis in cancer patients. J Clin Oncol 38(Supplemental 15). e-Pub 2020.
- Khurana S, Abu-Sbeih H, Ma W, Foo WC, Wang Y. Eosinophilic colitis in cancer patients. Gastroenterology 158(6):S1159-S1160. e-Pub 2020.
- Dhingra S, Heredia MM, Taggart MW, Foo WC, Rashid A, May S, Wang H. Inter-Observer Variability and Challenges in Intraoperative Assessment of Pancreatic Resection Margins. Lab Invest 100(Supplemental 1):1641-1651, 2020. e-Pub 2020.
- Hailemichael Y, Johnson DH, Foo WC, Hess K, Haymaker C, Saberian C, Bentebibel B, Burton E, Wang Y, Woodman S, Hwu P, Diab A. Interleukin-6 blockade to de-couple CTLA-4 blockade colitis from anti-tumor efficacy. J Immunother Cancer 7, 2019. e-Pub 2019.
- Johnson DH, Hailemichael Y, Foo WC, Hess KR, Haymaker CL, Wani KM, Lazar AJ, Saberian CM, Bentebibel SE, Burton EM, Abu-Sbeih H, Wang Y, Hwu P, Diab A. Interleukin-6 is potential target to de-couple checkpoint inhibitor-induced colitis from antitumor immunity. J Clin Oncol 37(Supplement 15):2616-2616, 2019. e-Pub 2019.
- Ludford K, Cohen R, Foo WC, Thomas JV, Parc Y, Svrcek M, Kopetz S, Andre T, Overman MJ. Evaluation of complete pathological remission rates in surgically resected MSI-high metastatic colorectal cancers (mCRC). J Clin Oncol 37(Supplement 15):e15046-e15046, 2019. e-Pub 2019.
- Jacome AA, Raghav K, Shaw KR, Fournier KF, Royal RE, Taggart MW, Foo WC, Matamoros AA, Ahmed SU, Guerra JL, Overman MJ, Eng C. Prognostic value of genomic alterations (GA) on overall survival in appendiceal adenocarcinoma (AA). J Clin Oncol 37(Supplement 4):554-554, 2019. e-Pub 2019.
- Scally CP, Robinson K, Beaty K, Rafeeq S, Raghav K, Eng C, Overman M, Foo WC, Taggart MW, Mansfield P, Royal R, Fournier K. Prognostic significance of acellular mucin in patients undergoing cytoreductive surgery and HIPEC (CRS/HIPEC) for appendiceal neoplasm. Ann Surg Oncol 26:S49-S49, 2019. e-Pub 2019.
- Lopez A, Chen H, Harada K, Bhutani MS, Weston B, Lee JH, Maru DM, Foo WC, Rogers JE, Thomas I, Amlashi FG, Blum-Murphy MA, Rice DC, Hofstetter WL, Nguyen Q, Ajani JA. Taxane-based or platinum-based combination chemotherapy given concurrently with radiation followed by surgery resulting in high cure rates in esophageal cancer patients. J Clin Oncol 36(Supplement 15):e16051-e16051, 2018. e-Pub 2018.
- Patel V, Samdani R, Abraham S, Estrella J, Taggart MW, Tan D, Wang H, Rashid A, Foo WC, Maru D. Clinicopathologic predictors of long-term responders to trastuzumab-based therapy in stage IV esophageal adenocarcinoma. Lab Invest 98(Supplement 1):294-295, 2018. e-Pub 2018.
- Solis LM, Foo WC, Parra E, Mino B, Abdel-Wahab R, Wistuba I, Kwong L, Javle M, Shroff R. Tumor-associated inflammatory cells and immune-checkpoints markers correlates with clinicopathological characteristics in intrahepatic cholangiocarcinoma (ICC). Lab Invest 98(Supplement 1):649-650, 2018. e-Pub 2018.
- Kazemimood R, Foo WC, Abraham S, Rashid A, Taggart MW. Updated American Joint Commission on Cancer staging for ileal neuroendocrine tumors predicts recurrence-free interval. Lab Invest 98(Supplement 1):274, 2018. e-Pub 2018.
- Raghav K, Fournier KF, Johnson B, Taggart MW, Foo WC, Matamoros A, Mehdizadeh A, Ahmed SU, Guerra JL, Mansfield PF, Royal RE, Eng C, Overman MJ. Interplay of grade and stage on survival outcomes in appendiceal adenocarcinoma: corroboration of the AJCC cancer staging classification. J Clin Oncol 36(4):773, 2018. e-Pub 2018.
- Pestana R, Solis LM, Wang X, Abdel-Wahab R, Chen HC, Foo WC, Kwong L, Javle M, Wistuba I, Scrhoff RT. Immunoprofiling in intrahepatic cholangiocarcinoma (IHCC). J Clin Oncol 36(Supplemental), 2018. e-Pub 2018.
- Raghav K, Fournier KF, Johnson B, Taggart MW, Foo WC, Matamoros A, Mehdizadeh A, Ahmed S, Guerra JL, Mansfield PF, Royal RE, Overman MJ, Eng C. Comprehensive genomic profiling of appendiceal adenocarcinoma. J Clin Oncol 36(Supplemental):298-298, 2018. e-Pub 2018.
- Marcus R, Foo WC, Maitra A, Gupta S. Functional role of a novel epigenetic regulator in intrahepatic cholangiocarcinoma. J Am Coll Surg 225(4):S192, 2017. e-Pub 2017.
- Zhang HC, Dedania, BK, Foo WC, Miller E. Adverse Hepatobiliary Effects of Pegaspargase: Diagnostic Features and Potential Treatment. Am J Gastroenterol 112:S1179-S1180, 2017. e-Pub 2017.
- Marcus R, Foo WC, Maitra A, and Gupta S. Development of a novel mouse model for intrahepatic cholangiocarcinoma. Cancer Res 77(13 Supplement):1392, 2017. e-Pub 2017.
- Gunter JR, Chadha AS, Yang P, Munsell MF, Das P, Delclos ME, Foo WC, Kaur H, Clemons M, Mathew GG, Chang GJ, Rodriguez-Bigas MA, Skibber JM, Bhutani M, Raju GS, Eng C, Guha S, Krishnan S. A phase 2 randomized double blinded study evaluating the efficacy of curcumin with pre-operative chemoradiation for rectal cancer. Int J Radiat Oncol Biol Phys 98(2):E7, 2017. e-Pub 2017.
- Marcus R, Foo WC, Maitra A, Gupta S. Development of a novel animal model for intrahepatic cholangiocarcinoma. HPB (Oxford) 19:S72, 2017. e-Pub 2017.
- Hui L, Rashid A, Foo WC, Katz MH, Fleming JB, Tamm EP, and Wang H. Significance of T1a and T1b carcinoma arising in mucinous cystic neoplasm of pancreas. Lab Invest 97:445A, 2017. e-Pub 2017.
- Chatterjee D, Katz MH, Foo WC, Sundar M, Wang H, Varadhachary GR, Wolff RA, Lee JE, Maitra A, Fleming JB, Rashid A, and Wang H. Prognostic significance of new AJCC tumor (T) stage in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant therapies. Lab Invest 97:442A, 2017. e-Pub 2017.
- Foo WC, Overman M, Vilar-Sanchez E, Abraham S, Taggart A, MW. High level microsatellite instability in appendiceal carcinomas. Lab Invest 97:172A, 2017. e-Pub 2017.
- Marcus RK, Foo WC, Evans D, Maitra A, Gupta A. Development of a Novel Model for Intrahepatic Cholangiocarcinoma. Ann Surg Oncol 24:S104-S104, 2017. e-Pub 2017.
- Roberts LR, Farshidfar F, Zheng S, Gingras M, Newton Y, Shih J, Robertson AG, Hinoue T, Hoadley KA, Gibbs R, Roszik J, Covington K, Wu C, Shinbrot E, Stransky N, Hegde AM, Yang JD, Reznik E, Sadeghi S, Pedamallu CS, Ojesina AI, Hess J, Auman JT, Rhie SK, Bowlby R, Borad MJ, Stuart J, Sander C, Akbani R, Cherniack AD, Laird PW, Deshpande V, Mounajjed T, Foo WC, Torbenson M, Kleiner DE, Wheeler DA, Mcree AJ, Bathe OF, Andersen JB, Bardeesy N, Kwong LN. Integrative genomic analysis of cholangiocarcinoma identifies distinct IDH-mutant molecular profiles. Hepatology 64:227A, 2016. e-Pub 2016.
- Ronquillo Jr N, Rafeeq S, Fournier K, Mansfield P, Taggart MW, Foo WC. Completion resections of low grade appendiceal mucinous neoplasm with extra-appendiceal mucin and appendiceal margin involvement. Lab Invest 96:196A, 2016. e-Pub 2016.
- Jedrzkiewicz J, Foo WC, Mansfield P, Overman M, Rafeeq S, Rashid A, Taggart MW. Conventional colonic-type adenocarcinoma of the appendix: clinicopathologic comparison with cecal adenocarcinomas. Lab Invest 96:176A, 2016. e-Pub 2016.
- Agarwal A, Correa AM, Wang H, Maru D, Tan D, Abraham S, Taggart MW, Estrella JS, Foo WC, Hofstetter WL, Rashid A. Prospectively reported histologic tumor viability score and factors predicting long term survival in patients treated with trimodality therapy for primary esophageal adenocarcinoma. Lab Invest 96:159A, 2016. e-Pub 2016.
- Friedman F, Foo WC, Abraham S, Rashid A, Taggart, MW. Appendiceal goblet cell carcinoid tumors-findings after definitive resection. Lab Invest 96:172A, 2016. e-Pub 2016.
- Taggart MW, Foo WC, Abraham SC. Duplication of molecular testing at a tertiary care oncology center. Lab Invest 93:486A-487A, 2013. e-Pub 2013.
- Foo WC, Taggart MW, Abraham SC. Muscularis mucosae duplication and musculo-fibrous anomalies in squamous dysplasia of the esophagus. International Academy of Pathology 61(Supplement S1):79, 2012. e-Pub 2012.
- Krishna SG, Fleming JB, Ross WA, Bhutani MS, Krishna K, Foo WC, Gong Y, Weston BR, Raju GS, Lee JH. Non-ampullary duodenal carcinoids: role of endosonography (EUS) and outcome of endoscopic mucosal resection. Digestive Disease Week. Gastrointest Endosc 75(4):AB266, 2012. e-Pub 2012.
- Krishna SG, Ross WA, Fleming JB, Bhutani MS, Foo WC, Raju GS, Weston BR, Dang SM, Lee JH. Large non-ampullary duodenal adenomas (>= 1 cm): is EUS necessary before endoscopic mucosal resection (EMR). Gastrointest Endosc 75(4):AB262-AB263, 2012. e-Pub 2012.
- Foo WC, Rashid A, Wang H, Hamilton S, Katz MH, Lee JE, Gomez HF, Abbruzzese JL, Fleming JB, Wang H. Loss of PTEN expression in pancreatic ductal adenocarcinoma is associated with poor survival. Lab Invest 92:442A-443A, 2012. e-Pub 2012.
- Zhao Q, Weng S, Foo WC, Estrella JS, Yao JC, Wang H, Wang H, Rashid A. Loss of expression of DAXX and ATRX in low-grade neuroendocrine tumors (carcinoid tumors). Lab Invest 92:187A, 2012. e-Pub 2012.
- Krishna SG, Dang SM, Foo WC, Ross WA, Lee JH. Pancreatic involvement in multiple myeloma: clinical and diagnostic features for the gastroenterologist. Digestive Disease Week, 2012. e-Pub 2012.
- Foo WC, Colombo C, Whitting D, Hajibashi S, Wang WL, Lev D, Lazar A. FAP-assodated desmoid fibromatosis: a comparison to their sporadic counterparts. Lab Invest 91:13A-14A, 2011. e-Pub 2011.
- Foo WC, Wick MR, Hornick JL. Immunohistochemical staining for TLE1 distinguishes synovial sarcoma from histologic mimics. Lab Invest 90:20A, 2010. e-Pub 2010.
- Liang, CW, Rossi S, Dei Toss AP, Hornick JL, Foo WC, Fletcher JA. MicroGIST genomic aberrations highlight early mechanisms in GIST pathogenesis. Lab Invest 90:23A, 2010. e-Pub 2010.
- Foo WC, Carlson JW, Lyon E, Walton D, Farmer P, Nose V. Partners In pathology: a model for department-wide educational experience. Lab Invest 89:113A, 2009. e-Pub 2009.
- Hofer MD, Foo WC, Gordon G, Sugarbaker DJ, Bueno R, Corson JM, Chirieac LR. The extent of sarcomatoid component is an independent predictor of survival in malignant mesothelioma. Histopathology 53(Supplement 1):360, 2008. e-Pub 2008.
- Carlson JW, Lyon E, Walton D, Foo WC, Sievers AC, Shulman LN, Farmer P, Nose V. Partners in pathology: a collaborative model to bring pathology to resource poor settings. Lab Invest 88:284A-285A, 2008. e-Pub 2008.
- Foo WC, Hofer MD, Sugarbaker DJ, Corson JM, Chirieac LR. The accuracy of pretreatment biopsy of pleural malignant mesothelioma in predicting histopathologic type in extrapleural pneumonectomy. Lab Invest 88:341A-342A, 2008. e-Pub 2008.
Book Chapters
- Oppliger, F, Foo, WC, Chun, YS. Multigene Testing for Prognostication and Therapeutic Actionability. In: Colorectal Liver Metastasis, 467-473, 2022.
- Foo WC. Esophagus. In: Grossing, Staging, and Reporting. An Integrated Model of Modern Surgical Pathology. College of American Pathologists, 2021.
- Foo WC. Distal Extrahepatic Bile Duct. In: Grossing, Staging, and Reporting. An Integrated Model of Modern Surgical Pathology. College of American Pathologists, 2021.
- Foo WC. Perihilar Bile Duct. In: Grossing, Staging, and Reporting. An Integrated Model of Modern Surgical Pathology. College of American Pathologists, 2021.
- Foo WC. Gallbladder. In: Grossing, Staging, and Reporting. An Integrated Model of Modern Surgical Pathology. College of American Pathologists, 2021.
- Taggart MW, Foo WC, Lee SM. Tumors of the gastrointestinal intestinal system including the pancreas. In: Oncological Surgical Pathology. Springer Nature, 691-870, 2020.
- Foo WC, Wang H. Pathology and Molecular Pathology of Pancreatic Cancer. In: Pathology and Epidemiology of Cancer. Springer International Publishing, 489-509, 2017.
- Foo WC, Lazar A. Pathology of desmoid tumors. In: Desmoid tumors. Springer, Dordrecht, 17-28, 2012.
Books (edited and written)
- Oppliger, F, Foo, WC, Chun, YS. Multigene Testing for Prognostication and Therapeutic Actionability, 2022.
Patient Reviews
CV information above last modified March 27, 2026